Literature DB >> 12734415

DNA building blocks at the foundation of better survival.

Andrei Chabes1, Lars Thelander.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12734415     DOI： 10.4161/cc.2.3.354

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  9 in total

1.  Arabidopsis ribonucleotide reductases are critical for cell cycle progression, DNA damage repair, and plant development.

Authors:  Chunxin Wang; Zhongchi Liu
Journal:  Plant Cell       Date:  2006-01-06       Impact factor: 11.277

2.  Limiting replication initiation factors execute the temporal programme of origin firing in budding yeast.

Authors:  Davide Mantiero; Amanda Mackenzie; Anne Donaldson; Philip Zegerman
Journal:  EMBO J       Date:  2011-11-11       Impact factor: 11.598

3.  Role of arginine 293 and glutamine 288 in communication between catalytic and allosteric sites in yeast ribonucleotide reductase.

Authors:  Md Faiz Ahmad; Prem Singh Kaushal; Qun Wan; Sanath R Wijerathna; Xiuxiang An; Mingxia Huang; Chris Godfrey Dealwis
Journal:  J Mol Biol       Date:  2012-03-29       Impact factor: 5.469

4.  Thymidine kinase 1 silencing retards proliferative activity of pancreatic cancer cell via E2F1-TK1-P21 axis.

Authors:  Xiaole Zhu; Chenyuan Shi; Yunpeng Peng; Lingdi Yin; Min Tu; Qiuyang Chen; Chaoqun Hou; Qiang Li; Yi Miao
Journal:  Cell Prolif       Date:  2017-12-20       Impact factor: 6.831

5.  Ribonucleotide reductase metallocofactor: assembly, maintenance and inhibition.

Authors:  Caiguo Zhang; Guoqi Liu; Mingxia Huang
Journal:  Front Biol (Beijing)       Date:  2014-01-02

6.  Clofarabine Commandeers the RNR-α-ZRANB3 Nuclear Signaling Axis.

Authors:  Marcus J C Long; Yi Zhao; Yimon Aye
Journal:  Cell Chem Biol       Date:  2019-12-10       Impact factor: 8.116

7.  Phase I Trial of Triapine-Cisplatin-Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers.

Authors:  Charles A Kunos; Edward Chu; Della Makower; Andreas Kaubisch; Mario Sznol; Susan Percy Ivy
Journal:  Front Oncol       Date:  2017-04-04       Impact factor: 6.244

8.  Serum thymidine kinase 1 concentration as a predictive biomarker in prostate cancer.

Authors:  Per-Olof Lundgren; Bernhard Tribukait; Anders Kjellman; Ulf Norming; Kiran Jagarlmudi; Ove Gustafsson
Journal:  Prostate       Date:  2022-03-16       Impact factor: 4.012

9.  DCTPP1 prevents a mutator phenotype through the modulation of dCTP, dTTP and dUTP pools.

Authors:  Blanca Martínez-Arribas; Cristina E Requena; Guiomar Pérez-Moreno; Luis M Ruíz-Pérez; Antonio E Vidal; Dolores González-Pacanowska
Journal:  Cell Mol Life Sci       Date:  2019-08-03       Impact factor: 9.261
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.